From: Is neuroendocrine differentiation a prognostic factor in poorly differentiated colorectal cancer?
Clinicopathological factors | Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|---|
Number(%) | 3-year OS | P value | P value | RR | |
Age | 0.330 | ||||
<65 years | 43(61.4%) | 0.510 ± 0.077 | |||
≥65 years | 27(38.6%) | 0.407 ± 0.095 | |||
Gender | 0.582 | ||||
Male | 36(51.4%) | 0.408 ± 0.083 | |||
Female | 34(48.6%) | 0.529 ± 0.086 | |||
Tumor location | 0.092 | ||||
Colon | 45(64.3%) | 0.503 ± 0.083 | |||
Rectum | 25(35.7%) | 0.315 ± 0.094 | |||
T stage | 0.373 | ||||
T1 + T2 | 5(7.1%) | 0.600 ± 0.219 | |||
T3 + T4 | 65(92.9%) | 0.459 ± 0.062 | |||
N stage | <0.001* | <0.001* | 3.028 | ||
N0 | 19(27.1%) | 0.895 ± 0.070 | |||
N1 + N2 | 51(72.9%) | 0.310 ± 0.065 | |||
TNM stage | <0.001* | 0.384 | |||
I | 2(2.9%) | NAa | |||
II | 17(24.3%) | 0.882 ± 0.078 | |||
III | 51(72.8%) | 0.310 ± 0.065 | |||
NED | 0.003* | 0.111 | |||
+ | 36(51.4%) | 0.272 ± 0.075 | |||
- | 34(48.6%) | 0.674 ± 0.081 |